BRIEF published on 06/28/2024 at 09:05, 9 months 15 days ago CannaPharmaRx Reports Q1 2024 Financial Performance Financial Results Revenue Operating Expenses Licenses Strategic Agreements
PRESS RELEASE published on 06/28/2024 at 09:00, 9 months 15 days ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 10 months 23 days ago CannaPharmaRx organisera une conférence téléphonique pour les investisseurs le 21 mai 2024 Mise À Jour Financière Conférence Téléphonique Pour Les Investisseurs Production De Cannabis Doyen Medwid
BRIEF published on 05/20/2024 at 19:50, 10 months 23 days ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 10 months 23 days ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 10 months 24 days ago CannaPharmaRx organisera une conférence téléphonique avec les investisseurs Mise À Jour Financière Conférence Des Investisseurs CannapharmaRx Production De Cannabis Doyen Medwid
BRIEF published on 05/20/2024 at 18:35, 10 months 24 days ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 10 months 24 days ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
BRIEF published on 04/02/2024 at 12:05, 1 year ago CannapharmaRx rembourse avec succès les billets convertibles pour renforcer sa position Remboursement De Dette Billets Convertibles CannapharmaRx Production De Cannabis Intérêts Des Actionnaires
BRIEF published on 04/02/2024 at 12:05, 1 year ago CannapharmaRx Successfully Repays Convertible Notes to Strengthen Position Convertible Notes Debt Repayment Shareholder Interests CannapharmaRx Cannabis Production
Published on 04/12/2025 at 15:45, 1 day 2 hours ago New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 16 hours ago Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 18 hours ago Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/11/2025 at 23:45, 1 day 18 hours ago Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties
Published on 04/11/2025 at 21:45, 1 day 20 hours ago OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:23, 2 days ago EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:30, 2 days ago Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 2 days ago Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 2 days ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 2 days ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
